<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04036201</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R 41/2019</org_study_id>
    <nct_id>NCT04036201</nct_id>
  </id_info>
  <brief_title>Minimum Effective Volume of Local Anesthetic for Peribulbar Block.Does it Differ With the Eyeball Axial Length?</brief_title>
  <official_title>Minimum Effective Volume of Local Anesthetic for Peribulbar Block.Does it Differ With the Eyeball Axial Length?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to calculate the minimum effective volume of local anesthetic for
      peribulbar block in patients undergoing cataract extraction surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of this study is to estimate the minimum effective volume(MEV90) of local
      anesthetic and hyaluronic acid given for local anesthesia of the eye for 2 different axial
      length groups of patients undergoing eye surgery. Volume assignment was carried out using a
      biased coin design (BCD) up-and-down sequential method (UDM), where the volume given to each
      patient depends on the response of the previous one. The MEV90 was calculated using isotonic
      regression with bias-corrected 95% confidence interval (CI) derived by boots trapping. The
      mean value of the estimate was obtained from 3000 bootstrap samples.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 31, 2019</start_date>
  <completion_date type="Actual">October 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The minimum effective volume of local anesthetic of the eye in relation to the eyeball axial length.</measure>
    <time_frame>10 minutes</time_frame>
    <description>The minimum effective volume of local anesthetic in peribulbar block in relation to the eyeball axial length.The minimum volume which will achieve adequate sensory and motor block within 10 minutes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Peribulbar Block</condition>
  <arm_group>
    <arm_group_label>Group 1(22-24 mm)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1 (patients with axial length between 22 and 24 mm): received a mixture of bupivacaine 0.5% (3ml) + lidocaine 2% (3ml) + hyalurindase 150 IU (1 ml) to a total volume of 7 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2(24.1-26 mm)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2 (patients with axial length between 24.1 and 26 mm): received a mixture of bupivacaine 0.5% (3ml) + lidocaine 2% (3ml) + hyaluronidase 150 IU (1 ml) to a total volume of 7 m</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>peribulbar block</description>
    <arm_group_label>Group 1(22-24 mm)</arm_group_label>
    <arm_group_label>Group 2(24.1-26 mm)</arm_group_label>
    <other_name>hyaluronic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  we allocated adult patients aged 40-70 years, of both gender, American Society of
             Anesthesiologists (ASA) II - III, listed for elective cataract extraction using phaco
             emulsification technique with intraocular lens implantation surgery.

        Exclusion Criteria:

          -  Patients known to have any systemic contraindications (as severe hypertension) or
             allergy to the local anesthetic, those who refused local anesthesia, high myopes
             (axial length &gt; 26 mm), patients with a single eye, those with complicated vitreous
             hemorrhage, ocular infection, or associated glaucoma have been excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WALID Nofal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sanaa el Fawal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wail Abdelaal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eman Sabek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Centre of Radiation Research and Technology, Atomic Energy Authority</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine ,Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <state>القاهرة</state>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>July 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2019</study_first_posted>
  <last_update_submitted>October 18, 2019</last_update_submitted>
  <last_update_submitted_qc>October 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Walid Nofal</investigator_full_name>
    <investigator_title>Assisstant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Peribulbar block</keyword>
  <keyword>minimum effective volume</keyword>
  <keyword>axial eye length</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

